RhumbLine Advisers’s Genfit GNFT Stock Holding History

RhumbLine Advisers’s Portfolio GNFT Stock Details GNFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$30	–	4129
2025 Q4	$30	Hold	5	–	–	﹤0.01%	4114
2025 Q3	$18	Hold	5	–	–	﹤0.01%	4106
2025 Q2	$18	Sell	5 -673	-99%	-$2.65K	﹤0.01%	4128
2025 Q1	$2.43K	Hold	678	–	–	﹤0.01%	3967
2024 Q4	$2.49K	Hold	678	–	–	﹤0.01%	4020
2024 Q3	$4.06K	Hold	678	–	–	﹤0.01%	4006
2024 Q2	$2.45K	Hold	678	–	–	﹤0.01%	4166
2024 Q1	$2.41K	Hold	678	–	–	﹤0.01%	4072
2023 Q4	$2.6K	Sell	678 -125	-16%	-$414	﹤0.01%	4070
2023 Q3	$2.63K	Hold	803	–	–	﹤0.01%	4082
2023 Q2	$2.84K	Buy	+803	New	+$3.31K	﹤0.01%	4171

RhumbLine Advisers's GNFT Position: Q1 2026 in Review

RhumbLine Advisers sold out of Genfit (GNFT) in Q1 2026, closing a stake of 5 shares — an estimated $30 sold.

RhumbLine Advisers first reported a position in GNFT in Q2 2023 and held it in 11 quarters. The position peaked at $4.06K in Q3 2024. 0 funds tracked by Wall St. Rank hold GNFT as of Q1 2026.

RhumbLine Advisers reported no remaining Genfit position as of Q1 2026 after selling out during the quarter.
RhumbLine Advisers sold 5 Genfit shares in Q1 2026, an estimated $30.
RhumbLine Advisers first reported a position in Genfit in Q2 2023 and held it in 11 quarters.
RhumbLine Advisers's Genfit position peaked at $4.06K in Q3 2024.
0 funds tracked by Wall St. Rank held Genfit as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.